tiprankstipranks
Trending News
More News >
Cochlear Limited (CHEOF)
OTHER OTC:CHEOF
US Market
Advertisement

Cochlear (CHEOF) Stock Forecast & Price Target

Compare
31 Followers
See the Price Targets and Ratings of:

CHEOF Analyst Ratings

Hold
11Ratings
Hold
3 Buy
6 Hold
2 Sell
Based on 11 analysts giving stock ratings to
Cochlear
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CHEOF Stock 12 Month Forecast

Average Price Target

$205.00
▲(10.63% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is $205.00 with a high forecast of $232.82 and a low forecast of $182.15. The average price target represents a 10.63% change from the last price of $185.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"163":"$163","198":"$198","233":"$233","180.5":"$180.5","215.5":"$215.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":232.824,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$232.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$205.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":182.14554,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$182.15</span>\n  </div></div>","useHTML":true}}],"tickPositions":[163,180.5,198,215.5,233],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,196.9,199.66338461538462,202.42676923076922,205.19015384615386,207.95353846153847,210.71692307692308,213.4803076923077,216.24369230769233,219.00707692307694,221.77046153846155,224.53384615384616,227.2972307692308,230.0606153846154,{"y":232.824,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,196.9,197.52307692307693,198.14615384615385,198.76923076923077,199.3923076923077,200.01538461538462,200.63846153846154,201.26153846153846,201.8846153846154,202.5076923076923,203.13076923076923,203.75384615384615,204.37692307692308,{"y":205,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,196.9,195.76504153846153,194.63008307692309,193.4951246153846,192.36016615384617,191.2252076923077,190.09024923076925,188.95529076923077,187.82033230769233,186.68537384615385,185.5504153846154,184.41545692307693,183.28049846153846,{"y":182.14554,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":209.59,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":215.04,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":205.7,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":185.18,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":178.29,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":195.08,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.25,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.67,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197.61,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":199.01,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$232.82Average Price Target$205.00Lowest Price Target$182.15
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CHEOF
Morgan Stanley
Morgan Stanley
$183.12
Sell
-1.18%
Downside
Reiterated
09/26/25
Cochlear (CHEOF) Receives a Sell from Morgan Stanley
Citi
$228.9$209.28
Hold
12.94%
Upside
Downgraded
09/18/25
UBS downgrades Cochlear (CHEOF) to a Hold
TR | OpenAI - 4o Analyst forecast on CHEOF
TR | OpenAI - 4o
TR | OpenAI - 4o
$217.78
Buy
17.52%
Upside
Reiterated
09/18/25
AI Generated ArticleAI Generated Article
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$192.93
Hold
4.11%
Upside
Reiterated
09/15/25
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$192.93
Hold
4.11%
Upside
Reiterated
08/18/25
Ord Minnett Reaffirms Their Hold Rating on Cochlear (CHEOF)
Wilsons
$215.82
Hold
16.46%
Upside
Reiterated
08/18/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ceribell, Inc. (NASDAQ: CBLL) and Cochlear (Other OTC: CHEOF)
J.P. Morgan Analyst forecast on CHEOF
J.P. Morgan
J.P. Morgan
$199.47$227.59
Buy
22.82%
Upside
Reiterated
08/18/25
J.P. Morgan Remains a Buy on Cochlear (CHEOF)
Macquarie Analyst forecast on CHEOF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$176.91$193.52
Hold
4.43%
Upside
Reiterated
08/18/25
Macquarie Reaffirms Their Hold Rating on Cochlear (CHEOF)
Morgans
$184.01$195.9
Sell
5.71%
Upside
Downgraded
08/17/25
Cochlear (CHEOF) was downgraded to a Sell Rating at Morgans
Jefferies Analyst forecast on CHEOF
Jefferies
Jefferies
$231.52$232.82
Buy
25.64%
Upside
Reiterated
08/15/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Recursion Pharmaceuticals (NASDAQ: RXRX) and Cochlear (Other OTC: CHEOF)
Jarden
$176.76$182.15
Hold
-1.71%
Downside
Reiterated
08/15/25
Jarden Keeps Their Hold Rating on Cochlear (CHEOF)
RBC Capital Analyst forecast on CHEOF
RBC Capital
RBC Capital
$192.28$192.93
Hold
4.11%
Upside
Reiterated
08/15/25
RBC Capital Reaffirms Their Hold Rating on Cochlear (CHEOF)
UBS
$212.55$228.9
Buy
23.52%
Upside
Reiterated
08/15/25
UBS Sticks to Their Buy Rating for Cochlear (CHEOF)
Macquarie Analyst forecast on CHEOF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$177.63$176.91
Hold
-4.53%
Downside
Reiterated
07/16/25
Cochlear (CHEOF) Receives a Hold from Macquarie
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$186.39$192.93
Hold
4.11%
Upside
Reiterated
07/09/25
Cochlear (CHEOF) Receives a Hold from Ord Minnett
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CHEOF
Morgan Stanley
Morgan Stanley
$183.12
Sell
-1.18%
Downside
Reiterated
09/26/25
Cochlear (CHEOF) Receives a Sell from Morgan Stanley
Citi
$228.9$209.28
Hold
12.94%
Upside
Downgraded
09/18/25
UBS downgrades Cochlear (CHEOF) to a Hold
TR | OpenAI - 4o Analyst forecast on CHEOF
TR | OpenAI - 4o
TR | OpenAI - 4o
$217.78
Buy
17.52%
Upside
Reiterated
09/18/25
AI Generated ArticleAI Generated Article
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$192.93
Hold
4.11%
Upside
Reiterated
09/15/25
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$192.93
Hold
4.11%
Upside
Reiterated
08/18/25
Ord Minnett Reaffirms Their Hold Rating on Cochlear (CHEOF)
Wilsons
$215.82
Hold
16.46%
Upside
Reiterated
08/18/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ceribell, Inc. (NASDAQ: CBLL) and Cochlear (Other OTC: CHEOF)
J.P. Morgan Analyst forecast on CHEOF
J.P. Morgan
J.P. Morgan
$199.47$227.59
Buy
22.82%
Upside
Reiterated
08/18/25
J.P. Morgan Remains a Buy on Cochlear (CHEOF)
Macquarie Analyst forecast on CHEOF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$176.91$193.52
Hold
4.43%
Upside
Reiterated
08/18/25
Macquarie Reaffirms Their Hold Rating on Cochlear (CHEOF)
Morgans
$184.01$195.9
Sell
5.71%
Upside
Downgraded
08/17/25
Cochlear (CHEOF) was downgraded to a Sell Rating at Morgans
Jefferies Analyst forecast on CHEOF
Jefferies
Jefferies
$231.52$232.82
Buy
25.64%
Upside
Reiterated
08/15/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Recursion Pharmaceuticals (NASDAQ: RXRX) and Cochlear (Other OTC: CHEOF)
Jarden
$176.76$182.15
Hold
-1.71%
Downside
Reiterated
08/15/25
Jarden Keeps Their Hold Rating on Cochlear (CHEOF)
RBC Capital Analyst forecast on CHEOF
RBC Capital
RBC Capital
$192.28$192.93
Hold
4.11%
Upside
Reiterated
08/15/25
RBC Capital Reaffirms Their Hold Rating on Cochlear (CHEOF)
UBS
$212.55$228.9
Buy
23.52%
Upside
Reiterated
08/15/25
UBS Sticks to Their Buy Rating for Cochlear (CHEOF)
Macquarie Analyst forecast on CHEOF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$177.63$176.91
Hold
-4.53%
Downside
Reiterated
07/16/25
Cochlear (CHEOF) Receives a Hold from Macquarie
Ord Minnett Analyst forecast on CHEOF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$186.39$192.93
Hold
4.11%
Upside
Reiterated
07/09/25
Cochlear (CHEOF) Receives a Hold from Ord Minnett
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cochlear

1 Month
xxx
Success Rate
4/7 ratings generated profit
57%
Average Return
-0.41%
upgraded a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of -0.41% per trade.
3 Months
xxx
Success Rate
5/6 ratings generated profit
83%
Average Return
-2.43%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of -2.43% per trade.
1 Year
David StantonJefferies
Success Rate
5/6 ratings generated profit
83%
Average Return
-3.38%
reiterated a buy rating last month
Copying David Stanton's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of -3.38% per trade.
2 Years
xxx
Success Rate
5/6 ratings generated profit
83%
Average Return
-5.87%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of -5.87% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CHEOF Analyst Recommendation Trends

Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
5
8
11
11
8
Buy
0
0
0
0
0
Hold
3
9
9
16
15
Sell
1
2
2
4
3
Strong Sell
0
0
0
0
0
total
9
19
22
31
26
In the current month, CHEOF has received 8 Buy Ratings, 15 Hold Ratings, and 3 Sell Ratings. CHEOF average Analyst price target in the past 3 months is 205.00.
Each month's total comprises the sum of three months' worth of ratings.

CHEOF Financial Forecast

CHEOF Earnings Forecast

Next quarter’s earnings estimate for CHEOF is $2.10 with a range of $1.97 to $2.22. The previous quarter’s EPS was $1.89. CHEOF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.82% of the time in the same period. In the last calendar year CHEOF has Outperformed its overall industry.
Next quarter’s earnings estimate for CHEOF is $2.10 with a range of $1.97 to $2.22. The previous quarter’s EPS was $1.89. CHEOF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.82% of the time in the same period. In the last calendar year CHEOF has Outperformed its overall industry.

CHEOF Sales Forecast

Next quarter’s sales forecast for CHEOF is $812.45M with a range of $771.71M to $837.80M. The previous quarter’s sales results were $791.05M. CHEOF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 54.41% of the time in the same period. In the last calendar year CHEOF has Preformed in-line its overall industry.
Next quarter’s sales forecast for CHEOF is $812.45M with a range of $771.71M to $837.80M. The previous quarter’s sales results were $791.05M. CHEOF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 54.41% of the time in the same period. In the last calendar year CHEOF has Preformed in-line its overall industry.

CHEOF Stock Forecast FAQ

What is CHEOF’s average 12-month price target, according to analysts?
Based on analyst ratings, Cochlear Limited’s 12-month average price target is 205.00.
    What is CHEOF’s upside potential, based on the analysts’ average price target?
    Cochlear Limited has 10.63% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CHEOF a Buy, Sell or Hold?
          Cochlear Limited has a consensus rating of Hold which is based on 3 buy ratings, 6 hold ratings and 2 sell ratings.
            What is Cochlear Limited’s price target?
            The average price target for Cochlear Limited is 205.00. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $232.82 ,the lowest forecast is $182.15. The average price target represents 10.63% Increase from the current price of $185.31.
              What do analysts say about Cochlear Limited?
              Cochlear Limited’s analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of CHEOF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis